NanoVision Diagnostics


Peer-Reviewed Clinical Journal Publications

Hartman DJ, Krasinskas AM, Bista RK, Uttam S, Staton KD, Rizvi R, Slivka A, Brand RE, Liu Y. Assessment of nuclear nano-morphology marker to improve the detection of malignancy from bile duct biopsies, American Journal of Clinical Pathology 2014; In press.

Fasanella KE, Bista RK, Staton K, Rizvi S, Uttam S, Zhao C, Sepulveda A, Brand RE, McGrath K, and Liu Y. Nuclear Nano-architecture Markers of Gastric Cardia and Upper Squamous Esophagus Detect Esophageal Cancer “Field Effect”, Journal of Cancer 2013; 4(8): 626-634. PMC3805990

Bista RK, Wang P, Bhargava R, Uttam S, Hartman DJ, Brand RE, Liu Y. Nuclear nano-morphology markers of histologically normal cells detect the “field effect” of breast cancer. Breast Cancer Res Treat 2012; 135(1): 115-124.  

Peer-reviewed Abstracts in Clinical Conferences

Zaibo Li, Rohit Bhargava,  Kevin Staton,  Hong Wang,  Shikhar Uttam, Randall E. Brand, Atilla Soran,Gretchen M. Ahrendt and Yang Liu. Nuclear Nano-morphology Markers Predict Breast Cancer Risk in Patients with Atypical Breast Epithelial Hyperplasia. USCAP annual meeting, San Diego 2014.

Hashash JG, Bista RK, Staton KD, Hartman DJ, Alnabhan S, Baidoo L, Regueiro M, Schwartz M, Binion DG, Brand R, Liu Y. Nuclear Nano-Morphology Markers From Rectal Tissue Predict Colonic Dysplasia/Neoplasia in Ulcerative Colitis Patients, Gastroenterology 2013; 144(5), Supplement 1: S-175-S-176.

Alnabhan S, Bista RK, Staton KD, Uttam S, Hartman DJ, Liu Y, Brand R. Optical Markers Measured in Duodenal Tissue Can Distinguish Mucinous From Non-Mucinous Pancreatic Cysts, Gastroenterology 2013; 144(5), Supplement 1: S-89.

Sepulveda A, Yao Y, Uehara T, Jhala N, Sepulveda J, Ganguly T, Liu Y, Brand R, Falk G. Mutational Analysis by Next-Generation Sequencing of Pre-neoplastic Intestinal Metaplasia and Neoplastic Lesions in Barrett’s Esophagus from Endoscopic Samples, Gastroenterology¬† 2013; 144 (5), Supplement 1: Page S-74.

Bista RK, Uttam S, Hartman DJ, Qiu W, Yu J, Zhang L, Brand R, Liu Y. Investigation of Nuclear Nano-Morphology Markers as a Novel Biomarker for Cancer Risk Assessment Using a Mouse Model, Gastroenterology 2012; 142(5): S532.

Hashash JG, Bista RK, Hartman DJ, Regueiro M, Schwartz M, Staton K, Baidoo L, Binion D, Brand RE, Liu Y. Nuclear nano-morphology markers from rectal tissue for the surveillance of colorectal cancer in patients with ulcerative colitis. Gastroenterology 2012; 142(5): S538-S539.

Fasanella KE, Bista RK, Staton K, Brand RE, McGrath K, Liu Y. Assessment of gastric cardia to monitor the response to endoscopic therapy in patients with esophageal dysplasia and adenocarcinoma. Gastroenterology 2012; 142(5): S749-S750.

Hashash JG, Bista RK, Hartman DJ, Qiu W, Wang P, Zhang L, Brand R, Liu Y. Nuclear Refractive Index Detects the Field Effect of Carcinogenesis. Gastroenterology 2011;140:S-339.

Krasinskas AM, Bista RK, Rizvi S, Hartman DJ, Sanders M, Gelrud A, Slivka A, Brand R, Liu Y. Assessment of Nuclear Refractive Index to Improve the Diagnostic Accuracy of Cholangiocarcinoma of Bile Duct Biopsies. Gastroenterology 2011;140:S-68.

Rizvi S, Davison JM, Bista RK, Wang P, Holinga J, Staton KD, Hartman DJ, Brand R, Fasanella KE, Liu Y, McGrath K. Nuclear Refractive Index Properties of Non-Dysplastic Metaplastic Cells to Detect the Presence of Esophageal High-Grade Dysplasia and Adenocarcinoma From Barrett's Esophagus. Gastroenterology 2011;140:S-217.

Brokl DA, Lo DY, Khalbuss WE, Wang P, Bista RK, Uttam S, Liu Y, Brand R. Spatial-Domain Low-Coherence Quantitative Phase Microscopy to Improve the Cytological Diagnosis of Pancreatic Cancer. Gastroenterology 2011;140:S-53.